Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yuna Ribeiro"'
Autor:
João Guilherme Pessôa Léo, Camila Bocchi Siqueira, Jorgeth de Oliveira Carneiro da Motta, Ingrid Faber de Vasconcellos, Yuna Ribeiro de Araujo, Felipe Von Glehn, Patrícia Shu Kurizky, Ciro Martins Gomes, Cláudia Porto, Maria Stella Cochrane Feitosa
Publikováno v:
Anais Brasileiros de Dermatologia, Vol 99, Iss 5, Pp 736-739 (2024)
Externí odkaz:
https://doaj.org/article/b87746662cb64f73bac9e87b0557dfe8
Autor:
Yara Dadalti Fragoso, Christian Cardoso Arruda, Walter Oleschko Arruda, Joseph Bruno Bidin Brooks, Alfredo Damasceno, Carlos Augusto de Albuquerque Damasceno, Alessandro Finkelsztejn, Juliana Finkelsztejn, Paulo Diniz da Gama, Maria Cristina Brandão Giacomo, Sidney Gomes, Marcus Vinicius Magno Goncalves, Andre Palma da Cunha Matta, Marilia Manprim de Morais, Enedina Maria Lobato de Oliveira, Yuna Ribeiro, Henry Koiti Sato, Carlos Bernardo Tauil
Publikováno v:
Arquivos de Neuro-Psiquiatria, Vol 72, Iss 9, Pp 712-714 (2014)
Fingolimod is a new and efficient treatment for multiple sclerosis (MS). The drug administration requires special attention to the first dose, since cardiovascular adverse events can be observed during the initial six hours of fingolimod ingestion. T
Externí odkaz:
https://doaj.org/article/d06c93940b6144ccb01a7a79800388d9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Joseph Bruno Bidin Brooks, Maria Lucia Brito Ferreira, Sidney Gomes, Alfredo Damasceno, Cristiane Franklin Rocha, Heloisa Helena Ruocco, André Palma da Cunha Matta, Tarso Adoni, Carlos Bernardo Tauil, Rodrigo Assad Diniz da Gama, Vera Lúcia Ferreira Vieira, Renata Simm, Eber Castro Correa, Soniza Vieira Alves-Leon, Suzana C. Nunes Machado, Paulo Diniz da Gama, Jefferson Becker, Taysa Alexandrino Goncalves Jube Ribeiro, Samira Luisa Apostolos-Pereira, Claudia Cristina Ferreira Vasconcelos, Henry Sato, Maria Fernanda Mendes, Anderson Kuntz Grzesiuk, Carlos Augusto de Albuquerque Damasceno, Marcus Goncalves, Yuna Ribeiro de Araujo, Yara Dadalti Fragoso
Publikováno v:
Expert review of clinical pharmacology. 9(4)
Natalizumab is a therapeutic option for treating multiple sclerosis (MS) and is particularly efficacious for patients with highly active disease. A long washout period has been recommended between withdrawal of natalizumab and start of fingolimod (an
Autor:
Joseph Bruno Bidin Brooks, Alfredo Damasceno, Christian Cardoso Arruda, Carlos Bernardo Tauil, Henry Koiti Sato, Yuna Ribeiro, Juliana Finkelsztejn, André Palma da Cunha Matta, Alessandro Finkelsztejn, Enedina Maria Lobato de Oliveira, Marcus Goncalves, Maria Cristina Brandao Giacomo, Marilia Manprim de Morais, Yara Dadalti Fragoso, Paulo Diniz da Gama, Carlos Augusto de Albuquerque Damasceno, Sidney Gomes, Walter Oleschko Arruda
Publikováno v:
Arquivos de Neuro-Psiquiatria, Vol 72, Iss 9, Pp 712-714 (2014)
Arquivos de Neuro-Psiquiatria, Volume: 72, Issue: 9, Pages: 712-714, Published: SEP 2014
Arquivos de Neuro-Psiquiatria v.72 n.9 2014
Arquivos de neuro-psiquiatria
Academia Brasileira de Neurologia
instacron:ABNEURO
Arquivos de Neuro-Psiquiatria, Volume: 72, Issue: 9, Pages: 712-714, Published: SEP 2014
Arquivos de Neuro-Psiquiatria v.72 n.9 2014
Arquivos de neuro-psiquiatria
Academia Brasileira de Neurologia
instacron:ABNEURO
Fingolimod is a new and efficient treatment for multiple sclerosis (MS). The drug administration requires special attention to the first dose, since cardiovascular adverse events can be observed during the initial six hours of fingolimod ingestion. T
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.